These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35088395)

  • 21. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
    Gosselin R; Grant RP; Adcock DM
    Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme.
    Tripodi A; Chantarangkul V; Legnani C; Testa S; Tosetto A
    J Thromb Haemost; 2018 Mar; 16(3):565-570. PubMed ID: 29322630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA.
    Pfrepper C; Behrendt LC; Bönigk H; Siegemund T; Metze M; Franke D; Petros S; Siegemund A
    Int J Lab Hematol; 2022 Feb; 44(1):193-201. PubMed ID: 34585540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure.
    Shaw JR; Li N; Nixon J; Moffat KA; Spyropoulos AC; Schulman S; Douketis JD
    J Thromb Haemost; 2022 Dec; 20(12):2953-2963. PubMed ID: 36200348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case series of massive direct oral anticoagulant ingestion-Treatment and pharmacokinetics data.
    Delrue M; Chevillard L; Stépanian A; Dragoni A; Camoin-Jau L; Voicu S; Malissin I; Deye N; Gainnier M; Siguret V; Mégarbane B
    Eur J Clin Invest; 2022 Jun; 52(6):e13746. PubMed ID: 35000196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the effect of factor Xa inhibitors on rotational thromboelastometry: a case series of bleeding patients.
    Mahamad S; Chaudhry H; Nisenbaum R; McFarlan A; Rizoli S; Ackery A; Sholzberg M
    J Thromb Thrombolysis; 2019 Feb; 47(2):272-279. PubMed ID: 30506352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples.
    Sevenet PO; Cucini V; Hervé T; Depasse F; Carlo A; Contant G; Mathieu O
    Int J Lab Hematol; 2020 Oct; 42(5):636-642. PubMed ID: 32567799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients-Analysis of Pharmaceuticals and Medical Devices Agency Data.
    Terayama Y
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1171-1181. PubMed ID: 28169097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Direct Oral Anticoagulants on Antithrombin Activity Testing Is Abolished by DOAC-Stop in Venous Thromboembolism Patients.
    Ząbczyk M; Natorska J; Kopytek M; Malinowski KP; Undas A
    Arch Pathol Lab Med; 2021 Jan; 145(1):99-104. PubMed ID: 33367661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
    Adachi T; Hoshino H; Takagi M; Fujioka S;
    Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolving DOAC interference on antithrombin activity testing on a FXa based method by the use of activated carbon.
    Vercruyssen J; Meeus P; Bailleul E
    Clin Chim Acta; 2023 Jan; 538():216-220. PubMed ID: 36574540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants.
    Schmitz EM; Boonen K; van den Heuvel DJ; van Dongen JL; Schellings MW; Emmen JM; van der Graaf F; Brunsveld L; van de Kerkhof D
    J Thromb Haemost; 2014 Oct; 12(10):1636-46. PubMed ID: 25142183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists.
    Shin SS; Marsh EB; Ali H; Nyquist PA; Hanley DF; Ziai WC
    Neurocrit Care; 2020 Apr; 32(2):407-418. PubMed ID: 32034657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
    Wu M; Gabriels J; Khan M; Shaban N; D'Amato S; Liu CF; Markowitz SM; Ip JE; Thomas G; Singh P; Lerman B; Patel A; Cheung JW
    Heart Rhythm; 2018 Apr; 15(4):496-502. PubMed ID: 29605015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs - A Systematic Review and Meta-analysis.
    Martini A; Harenberg J; Bauersachs R; Beyer-Westendorf J; Crowther M; Douxfils J; Elalamy I; Weiss C; Hetjens S
    TH Open; 2021 Jul; 5(3):e438-e448. PubMed ID: 34595388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice.
    Buijs JT; Laghmani EH; van den Akker RFP; Tieken C; Vletter EM; van der Molen KM; Crooijmans JJ; Kroone C; Le Dévédec SE; van der Pluijm G; Versteeg HH
    J Thromb Haemost; 2019 Jun; 17(6):951-963. PubMed ID: 30929299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An optimized dRVVT-based assay to estimate the intensity of anticoagulation in patients treated with direct oral anticoagulants.
    Sennesael AL; Exner T; Chatelain B; Lessire S; Larock AS; Vancraeynest C; Pochet L; Dogné JM; Spinewine A; Mullier F; Douxfils J
    Thromb Res; 2017 Sep; 157():29-37. PubMed ID: 28686914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients' Plasma Activity of Heparin, low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips.
    Harenberg J; Hetjens S; Weiss C
    Clin Appl Thromb Hemost; 2022; 28():10760296221083667. PubMed ID: 35275493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.